المؤلفون: Ao Liu, Liubo Xiong, Lian Wang, Han Zhuang, Xiao Gan, Mengying Zou, Xiaoming Wang

المصدر: BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-12 (2024)

مصطلحات موضوعية: Invasive aspergillosis, Antifungal agents, Primary therapy, Network meta-analysis, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1471-2334Test

الوصول الحر: https://doaj.org/article/250c1b4da4e143f8969fab9340a2f3afTest

المؤلفون: Gi-June Min, Sung Eun Kim, Tong Yoon Kim, Young-Woo Jeon, Joo Hyun O, Byung-Ock Choi, Gyeongsin Park, Suk-Woo Yang, Seok-Goo Cho

المصدر: Frontiers in Oncology, Vol 12 (2022)

مصطلحات موضوعية: orbital, lymphoma, primary therapy, long-term outcome, limited-stage, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.769530/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/add0d9dc41da4bfd824d350490a82b6eTest

المؤلفون: Felix Zulhendri, Conrad O. Perera, Steven Tandean, Rizky Abdulah, Herry Herman, Andreas Christoper, Kavita Chandrasekaran, Arfiza Putra, Ronny Lesmana

المصدر: Biomedicine & Pharmacotherapy, Vol 146, Iss , Pp 112595- (2022)

مصطلحات موضوعية: Propolis, Respiratory tract, Systematic review, Primary therapy, Adjunctive therapy, Nutraceutical, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S0753332221013822Test; https://doaj.org/toc/0753-3322Test

الوصول الحر: https://doaj.org/article/81659b1b26ec403a95c7b77cd3a6401eTest

المؤلفون: NBCS Collaborators, ABCTB Investigators, kConFab-AOCS Investigators, Ahearn, Thomas U., Zhang, Haoyu, Michailidou, Kyriaki, Blomqvist, Carl, Nevanlinna, Heli

المساهمون: Medicum, HUS Comprehensive Cancer Center, Department of Oncology, Clinicum, Department of Obstetrics and Gynecology, Biosciences, HUS Gynecology and Obstetrics

مصطلحات موضوعية: Breast cancer, Etiologic heterogeneity, Genetic predisposition, Common breast cancer susceptibility variants, GENOME-WIDE ASSOCIATION, INTERNATIONAL EXPERT CONSENSUS, SUSCEPTIBILITY LOCI, HISTOLOGICAL GRADE, PRIMARY THERAPY, HETEROGENEITY, PROGRESSION, 3122 Cancers

وصف الملف: application/pdf

العلاقة: Open Access funding provided by the National Institutes of Health (NIH) This project has been funded in part with Federal funds from the National Cancer Institute Intramural Research Program, National Institutes of Health. Dr. Nilanjan Chatterjee was supported by NHGRI (1R01 HG010480-01). Dr. Haoyu Zhang was supported by National Cancer Institute (1K99 CA256513). OncoArray genotyping was funded by the government of Canada through Genome Canada and the Canadian Institutes of Health Research (GPH-129344), the Ministere de l'Economie, de la Science et de l'Innovation du Quebec through Genome Quebec, the Quebec Breast Cancer Foundation for the PERSPECTIVE project, the US National Institutes of Health (NIH) (1 U19 CA 148065 for the Discovery, Biology and Risk of Inherited Variants in Breast Cancer (DRIVE) project and X01HG007492 to the Center for Inherited Disease Research (CIDR) under contract HHSN268201200008I), Cancer Research UK (C1287/A16563), the Odense University Hospital Research Foundation (Denmark), the National R&D Program for Cancer Control-Ministry of Health and Welfare (Republic of Korea) (1420190), the Italian Association for Cancer Research (AIRC; IG16933), the Breast Cancer Research Foundation, the National Health and Medical Research Council (Australia) and German Cancer Aid (110837). iCOGS genotyping was funded by the European Union (HEALTH-F2-2009-223175), Cancer Research UK (C1287/A10710, C1287/A10118 and C12292/A11174]), NIH grants (CA128978, CA116167 and CA176785) and the Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112 (GAME-ON initiative)), an NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, the Ministere de l'Economie, Innovation et Exportation du Quebec (PSR-SIIRI-701), the Komen Foundation for the Cure, the Breast Cancer Research Foundation and the Ovarian Cancer Research Fund. A full description of the funding is provided in the Additional file 4: Funding and Acknowledgement.; NBCS Collaborators , ABCTB Investigators , kConFab-AOCS Investigators , Ahearn , T U , Zhang , H , Michailidou , K , Blomqvist , C & Nevanlinna , H 2022 , ' Common variants in breast cancer risk loci predispose to distinct tumor subtypes ' , Breast Cancer Research , vol. 24 , no. 1 , 2 . https://doi.org/10.1186/s13058-021-01484-xTest; 7b9a8a00-a50f-426d-a61d-e9e8322d5153; http://hdl.handle.net/10138/338911Test; 000738606300002

الإتاحة: http://hdl.handle.net/10138/338911Test

المؤلفون: Breast Canc Assoc Consortium, Mavaddat, Nasim, Dorling, Leila, Carvalho, Sara, Blomqvist, Carl, Muranen, Taru A., Nevanlinna, Heli

المساهمون: Medicum, Clinicum, Department of Oncology, HUS Comprehensive Cancer Center, Research Program in Systems Oncology, HUS Gynecology and Obstetrics, Department of Obstetrics and Gynecology, Biosciences

مصطلحات موضوعية: INTERNATIONAL EXPERT CONSENSUS, BRCA2 MUTATION CARRIERS, PRIMARY THERAPY, MOLECULAR PORTRAITS, SUBTYPES, EXPRESSION, ACTIVATION, SUBCLASSES, PALB2, CHK2, 3122 Cancers

وصف الملف: application/pdf

العلاقة: The BRIDGES panel sequencing was supported by the European Union Horizon 2020 research and innovation program BRIDGES (grant 634935) and theWellcome Trust (v203477/Z/16/Z). The Breast Cancer Association Consortium (BCAC) is funded by the European Union's Horizon 2020 Research and Innovation Programme (grants 634935 and 633784 for BRIDGES and B-CAST, respectively) and the PERSPECTIVE I&I project, which is funded by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research, the Ministere de l'Economie et de l'Innovation du Quebec, through Genome Quebec, the Quebec Breast Cancer Foundation. Additional funding for BCAC is provided via the Confluence project, which is funded with intramural funds from the National Cancer Institute Intramural Research Program. The ABCS study was supported by the Dutch Cancer Society (grants NKI 2007-3839; 2009 4363). The ACP study is funded by the Breast Cancer Research Trust, UK. Prof Muir and Dr Lophatananon are supported by the National Institute of Health Research (NIHR) Manchester Biomedical Research Centre, the Allan Turing Institute under the Engineering and Physical Sciences Research Council grant EP/N510129/1. The work of the BBCC was partly funded by ELAN-Fond of the University Hospital of Erlangen. For BIGGS, Dr Saloustros is supported by the NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London. Dr Tomlinson is supported by the Oxford Biomedical Research Centre. The BREast Oncology GAlician Network (BREOGAN) is funded by Accion Estrategica de Salud del Instituto de Salud Carlos III FIS grant PI12/02125/Cofinanciado FEDER; Accion Estrategica de Salud del Instituto de Salud Carlos III FIS Intrasalud (grant PI13/01136), and grant PI17/00918/Cofinanciado FEDER. Funding was received from Xerencia de Xestion Integrada de Vigo-SERGAS, Instituto de Salud Carlos III grant 10CSA012E and Conselleria de Industria Programa Sectorial de Investigacion Aplicada grant EC11-192. The BSUCH study was supported by the Dietmar-Hopp Foundation, the Helmholtz Society, and the German Cancer Research Center. The CCGP is supported by funding from the University of Crete. The CECILE study was supported by Fondation de France, Institut National du Cancer, Ligue Nationale contre le Cancer, Agence Nationale de Securite Sanitaire, de l'Alimentation, de l'Environnement et du Travail, and Agence Nationale de la Recherche. The CGPS was supported by the Chief Physician Johan Boserup and Lise Boserup Fund, the Danish Medical Research Council, and Herlev and Gentofte Hospital. The CNIO-BCS was supported by the Instituto de Salud Carlos III, the Red Tematica de Investigacion Cooperativa en Cancer, and grants from the Asociacion Espanola Contra el Cancer and the Fondo de Investigacion Sanitario (PI11/00923 and PI12/00070). Dr Osorio is partially supported by FIS PI19/00640 supported by FEDER funds and the Spanish Network on Rare Diseases (CIBERER). COLBCCC is supported by the German Cancer Research Center. Dr Torres was in part supported by a postdoctoral fellowship from the Alexander von Humboldt Foundation. PROCAS is funded from NIHR grant PGfAR 0707-10031. Prof Evans and Dr Howell are supported by the NIHR Manchester Biomedical Research Centre (IS-BRC-1215-20007). The German Consortium of Hereditary Breast and Ovarian Cancer is supported by the German Cancer Aid (grants 110837 and 70114178) and Federal Ministry of Education and Research, Germany (grant 01GY1901).; Breast Canc Assoc Consortium , Mavaddat , N , Dorling , L , Carvalho , S , Blomqvist , C , Muranen , T A & Nevanlinna , H 2022 , ' Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes ' , JAMA Oncology , vol. 8 , no. 3 , 216744 . https://doi.org/10.1001/jamaoncol.2021.6744Test; ORCID: /0000-0002-5895-1808/work/116550944; 85124213071; 2d39267e-2ef4-49c3-ba66-5592932e343f; http://hdl.handle.net/10138/346408Test; 000747992000001

الإتاحة: http://hdl.handle.net/10138/346408Test

المؤلفون: Kersten, Marie Jose, Amaador, Karima, Minnema, Monique C., Vos, Josephine M. I., Nasserinejad, Kazem, Kap, Marcel, Kastritis, Efstathios, Gavriatopoulou, Maria, Kraan, Willem, Chamuleau, Martine E. D., Deeren, Dries, Tick, Lidwine W., Doorduijn, Jeanette K., Offner, Fritz, Boehmer, Lara H., Liu, Roberto D., Pals, Steven T., Dimopoulos, Meletios A.

المصدر: JOURNAL OF CLINICAL ONCOLOGY ; ISSN: 0732-183X ; ISSN: 1527-7755

مصطلحات موضوعية: Medicine and Health Sciences, INDUCED PERIPHERAL NEUROPATHY, ORAL PROTEASOME INHIBITOR, MULTIPLE-MYELOMA, PRIMARY THERAPY, PLASMA-CELLS, FOLLOW-UP, BORTEZOMIB, WM, RECOMMENDATIONS, MUTATIONS

وصف الملف: application/pdf

العلاقة: https://biblio.ugent.be/publication/01GT25AMTE8VGNKF9T712WBQDCTest; http://hdl.handle.net/1854/LU-01GT25AMTE8VGNKF9T712WBQDCTest; http://dx.doi.org/10.1200/JCO.21.00105Test; https://biblio.ugent.be/publication/01GT25AMTE8VGNKF9T712WBQDC/file/01GT25AYJXR8993EYKAHJMB86ETest

الإتاحة: https://doi.org/10.1200/JCO.21.00105Test
https://biblio.ugent.be/publication/01GT25AMTE8VGNKF9T712WBQDCTest
http://hdl.handle.net/1854/LU-01GT25AMTE8VGNKF9T712WBQDCTest
https://biblio.ugent.be/publication/01GT25AMTE8VGNKF9T712WBQDC/file/01GT25AYJXR8993EYKAHJMB86ETest

المؤلفون: Bilezikian, John P., Silverberg, Shonni J., Bandeira, Francisco, Cetani, Filomena, Chandran, Manju, Cusano, Natalie E., Ebeling, Peter R., Formenti, Anna Maria, Frost, Morten, Gosnell, Jessica, Lewiecki, E. Michael, Singer, Frederick R., Gittoes, Neil, Khan, Aliya A., Marcocci, Claudio, Rejnmark, Lars, Ye, Zhikang, Guyatt, Gordon, Potts, John T.

المصدر: Bilezikian , J P , Silverberg , S J , Bandeira , F , Cetani , F , Chandran , M , Cusano , N E , Ebeling , P R , Formenti , A M , Frost , M , Gosnell , J , Lewiecki , E M , Singer , F R , Gittoes , N , Khan , A A , Marcocci , C , Rejnmark , L , Ye , Z , Guyatt , G & Potts , J T 2022 , ' Management of Primary Hyperparathyroidism ' , Journal of Bone and Mineral Research ....

مصطلحات موضوعية: CELL/TISSUE SIGNALING—ENDOCRINE PATHWAYS, CLINICAL TRIALS, DISORDERS OF CALCIUM/PHOSPHATE METABOLISM, PARATHYROID-RELATED DISORDERS, PTH/VIT D/FGF23, Hyperparathyroidism, Primary/therapy, Humans, Systematic Reviews as Topic, Parathyroid Hormone

وصف الملف: application/pdf

العلاقة: https://portal.findresearcher.sdu.dk/da/publications/f0fdd5b3-8041-4887-954e-75bf19bfe953Test

الإتاحة: https://doi.org/10.1002/jbmr.4682Test
https://portal.findresearcher.sdu.dk/da/publications/f0fdd5b3-8041-4887-954e-75bf19bfe953Test
https://findresearcher.sdu.dk/ws/files/215611094/J_of_Bone_Mineral_Res_2022_Bilezikian_Management_of_Primary_Hyperparathyroidism.pdfTest

المؤلفون: Schmid, P., Cortes, J., Dent, R., Pusztai, L., McArthur, H., Kummel, S., Bergh, J., Denkert, C., Park, Y. H., Hui, R., Harbeck, N., Takahashi, M., Untch, M., Fasching, P. A., Cardoso, F., Andersen, J., Patt, D., Danso, M., Ferreira, M., Mouret-Reynier, M-A, Im, S-A, Ahn, J-H, Gion, M., Baron-Hay, S., Boileau, J-F, Ding, Y., Tryfonidis, K., Aktan, G., Karantza, V, O'Shaughnessy, J.

المساهمون: 임석아, Im, S-A

مصطلحات موضوعية: CLINICAL-FEATURES, PLUS CHEMOTHERAPY, PRIMARY THERAPY, ADVERSE EVENTS

العلاقة: New England Journal of Medicine, Vol.386 No.6, pp.556-567; 155307; https://hdl.handle.net/10371/179237Test; 000753100900011; 2-s2.0-85124776620

الإتاحة: https://doi.org/10.1056/NEJMoa2112651Test
https://hdl.handle.net/10371/179237Test

المؤلفون: Liu, Ao, Xiong, Liubo, Wang, Lian, Zhuang, Han, Gan, Xiao, Zou, Mengying, Wang, Xiaoming

المصدر: BMC Infect Dis ; ISSN:1471-2334 ; Volume:24 ; Issue:1

مصطلحات موضوعية: Antifungal agents, Invasive aspergillosis, Network meta-analysis, Primary therapy

العلاقة: https://doi.org/10.1186/s12879-024-09477-9Test; https://pubmed.ncbi.nlm.nih.gov/38867163Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11170913Test/

الإتاحة: https://doi.org/10.1186/s12879-024-09477-9Test
https://pubmed.ncbi.nlm.nih.gov/38867163Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11170913Test/

المؤلفون: Kuendgen, A., Nomdedeu, M., Tuechler, H., Garcia-Manero, G., Komrokji, R.S., Sekeres, M.A., Della Porta, M.G., Cazzola, M., DeZern, A.E., Roboz, G.J., Steensma, D.P., Van de Loosdrecht, A.A., Schlenk, R.F., Grau, J., Calvo, X., Blum, S., Pereira, A., Valent, P., Costa, D., Giagounidis, A., Xicoy, B., Döhner, H., Platzbecker, U., Pedro, C., Lübbert, M., Oiartzabal, I., Díez-Campelo, M., Cedena, M.T., Machherndl-Spandl, S., López-Pavía, M., Baldus, C.D., Martinez-de-Sola, M., Stauder, R., Merchan, B., List, A., Ganster, C., Schroeder, T., Voso, M.T., Pfeilstöcker, M., Sill, H., Hildebrandt, B., Esteve, J., Nomdedeu, B., Cobo, F., Haas, R., Sole, F., Germing, U., Greenberg, P.L., Haase, D., Sanz, G.

المصدر: Leukemia, vol. 35, no. 3, pp. 835-849

مصطلحات موضوعية: Aged, 80 and over, Biomarkers, Tumor/analysis, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myelodysplastic Syndromes/classification, Myelodysplastic Syndromes/diagnosis, Myelodysplastic Syndromes/therapy, Neoplasms, Second Primary/classification, Second Primary/diagnosis, Second Primary/therapy, Prognosis, Retrospective Studies, Risk Assessment/methods, Survival Rate

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32595214; info:eu-repo/semantics/altIdentifier/eissn/1476-5551; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_3892893785601; https://serval.unil.ch/notice/serval:BIB_389289378560Test; urn:issn:0887-6924; https://serval.unil.ch/resource/serval:BIB_389289378560.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_3892893785601Test

الإتاحة: https://doi.org/10.1038/s41375-020-0917-7Test
https://serval.unil.ch/notice/serval:BIB_389289378560Test
https://serval.unil.ch/resource/serval:BIB_389289378560.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_3892893785601Test